5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Ajanta Pharma Ltd.

•
ajantapharma.comBSE: 532331NSE: AJANTPHARM
Market Cap₹ 44,226 Cr.
Current Price
High / Low₹ 3,796 / 2,330
Stock P/E43.9
Book Value₹ 363
Price to Book8.30
Dividend Yield0.79 %
ROCE31.4 %
ROE24.2 %
Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 32.7%
  • Company has a good return on equity (ROE) track record: 3 Years ROE 24.8%
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 0.97x)
  • Company has been maintaining a healthy dividend payout of 36.9%

CONS

  • Promoter holding has decreased over last 2 years: -2.8pp
  • Stock is trading at 8.3x its book value
  • Company has delivered a poor profit growth of 7.0% over past five years
  • Expensive relative to growth - PEG of 2.3

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTYM150MOMNTM50NIFTY PHARMANIFTYLARGEMIDCAP250NIFTYMIDCAP150NIFTY MIDCAP 150
S.No.Name
1.SUNPHARMA1868.5037.06448315.740.862901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9482.7586.06251737.220.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4931.9086.01187593.620.77566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1129.0024.95112618.180.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1368.0032.79110515.040.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1933.2595.54104455.860.10362.07123.942026.3129.1018.2031.50
7.AUROPHARMA1690.0026.1997238.860.241032.0325.229150.3517.4412.7620.54
8.LUPIN2092.0017.3095660.020.861416.9816.018276.8934.2828.8629.59
9.DRREDDY1143.2029.6195420.610.70435.60-69.108099.80-5.2113.7510.63
10.MANKIND2266.0045.8293596.020.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2439.5538.2968850.120.10482.83927.884018.4831.3520.3520.03
12.AJANTPHARM3539.2538.9744226.120.79334.2230.891625.9624.8232.6726.05
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
1,0159451,0859261,0771,1291,1021,0141,2091,2201,2071,2111,489
7386727586997618267667648799318669721,136
Operating Profit277274327227316303336250329290341238353
OPM %27.29%28.95%30.15%24.53%29.32%26.83%30.52%24.62%27.26%23.73%28.26%19.66%23.69%
31521434284033184175266371
Interest12211121112-11
Depreciation32333333333335394042424443
Profit before Tax275290305226311309332228329322322258423
Tax %23.00%26.90%27.85%27.99%24.00%24.00%24.00%15.22%22.50%22.50%24.01%23.42%25.50%
Net Profit212212220163236235252193255250245197315
16.8416.8717.4812.9218.7718.7520.1615.4620.4119.9819.6115.7925.25

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
1,8041,8251,7732,1962,7193,1413,4113,9714,3224,8465,126
1,1701,2791,2911,6641,8022,2502,7122,8523,1173,6483,905
Operating Profit6345474815339178916991,1191,2051,1981,221
OPM %35.16%29.96%27.15%24.26%33.73%28.37%20.50%28.19%27.87%24.72%23.82%
6773102180104140133116120204235
Interest10097957533
Depreciation59577091111121127132140169172
Profit before Tax6415625136139029017001,0971,1801,2311,325
Tax %21.98%23.99%23.64%28.00%25.10%20.06%20.17%26.41%22.30%23.09%24.00%
Net Profit5004283924416767205598079179471,007
EPS56.7848.5844.5150.5577.5955.5243.6164.1273.4175.81—
Dividend Payout %22.89%0.00%20.04%25.71%12.16%11.27%15.77%79.54%38.14%36.94%—

COMPOUNDED SALES GROWTH

10 Years:
12%
5 Years:
12%
3 Years:
12%

COMPOUNDED PROFIT GROWTH

10 Years:
8%
5 Years:
7%
3 Years:
19%

STOCK PRICE CAGR

10 Years:
11%
5 Years:
20%
3 Years:
27%
1 Year:
36%

RETURN ON EQUITY

10 Years:
24%
5 Years:
23%
3 Years:
25%
Last Year:
24%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2022

Jun 22

1:2

Bonus issue & Audited Results

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital18181717171725252525
1,4851,9122,1232,4432,8673,1523,2213,3833,5954,195
621920273032283139
Trade Payables145211186303317274353384366472
95148418545684504796398826866
Total Liabilities1,7492,2922,7633,3283,9123,9774,4274,2174,8435,597
5731,0371,1521,4401,5101,4841,4841,4651,7421,845
Capital Work in Progress25361261131108153209256176258
1992018386157165553367482606
179317414436634635684678739845
00000001,2081,2261,366
Cash & Bank23393688152145270635091
5226378161,1471,3511,3951,227180428587
Total Assets1,7492,2922,7633,3283,9123,9774,4274,2174,8435,597

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
6673424154396657368627351,054804
Cash from Investing-340-201-137-116-163-66-501105-350-400
Cash from Financing-198-1-181-134-269-457-105-1,048-716-360
-118-6513519130-207-1245

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
66.2766.2666.2666.2666.2666.2566.2566.2563.48
8.369.119.268.868.868.537.978.267.68
17.4117.0917.0217.4817.5017.9018.5818.3621.80
0.010.010.010.010.010.010.010.010.00
7.947.527.457.397.387.327.197.127.03

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-31
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-31 - Ajanta Pharma Limited has informed the Exchange about

2026-08-31
Copy of Newspaper Publication

2026-08-31 - Ajanta Pharma Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-05
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-05 - Ajanta Pharma Limited has informed the Exchange about Participation in Investor Conference

2026-08-03
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-03 - Ajanta Pharma Limited has informed the Exchange about Transcript

2026-07-31
Copy of Newspaper Publication

2026-07-31 - Ajanta Pharma Limited has informed the Exchange about Copy of Newspaper Publication

2026-07-30
Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-30 - Ajanta Pharma Limited has informed the Exchange about Link of Recording

2026-07-30
General Updates

2026-07-30 - Ajanta Pharma Limited has informed the Exchange about ESOP Allotment

2026-07-30
Dividend

2026-07-30 - Ajanta Pharma Limited has informed the Exchange that Board of Directors at its meeting held on July 30, 2026, declared Select Dividend of Rs. 32 per equity share.

2026-07-30
Record Date

2026-07-30 - Ajanta Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 05-Aug-2026.

News

Recent coverage and analyst commentary for AJANTPHARM

Loading news…

🤖

AI Stock Analyst

Ajanta Pharma Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login